Microcrystalline Hydroxyapatite Compound in Prevention of Bone Loss in Corticosteroid-Treated Patients With Chronic Active Hepatitis.
Postgraduate Medical Journal - United Kingdom
doi 10.1136/pgmj.61.719.791
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 1, 1985
Authors
Publisher
BMJ